Qualigen Therapeutics (QLGN) announced they will be the first investors participating in the 2025 bridge round of funding for NanoSynex.

CARLSBAD, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the "Company”)announced today ...

Long-term business success is more a function of founder characteristics than the quality of the idea, or resources available ...

AnchorWatch's product enables users to manage and safeguard their Bitcoin through a distinctive multisig arrangement, with ...

Becca Rubenfeld and the AnchorWatch team recently unveiled a first-of-its-kind bitcoin custody plus insurance solution, which ...

Azercell Telecom” LLC, in partnership with the ADA University Foundation, is excited to announce the launch of the next phase ...

Maryam Hassani’s commitment to leveling the playing field in technology was the primary incentive for her to build Zealous, ...

Here's how you can defeat the overthinker's paradox: To avoid over-complicating projects, aim to create your first version, ...

Shiba Inu bulls, take note—at just $0.04, a growing volume of smart money is moving towards WallitIQ (WLTQ) instead.

Crypto analysts have predicted a 30,000% rally for WallitIQ (WLTQ) tokens in the upcoming bull market. The platform’s ...

Startups can implement Lean Six Sigma by targeting specific inefficiencies, such as optimizing order fulfillment or ...